All News

Eli Lilly, Incyte's JAK inhibitor Olumiant in combination therapy meets main goal of Phase III atopic dermatitis trial

Ref: Fidelity, PR Newswire

Tags: Top Story Incyte Lilly Dermatitis Clinical Research (R&D)Olumiant

Axcella Health Inc. Announces Appointment of Catherine A. Sohn, Pharm. D. to its Board of Directors

Ref: Business Wire

Tags: People News Axcella GSK Jazz Pharmaceuticals NeuralStem Rubius Therapeutics Corporate Affairs

Why Alexion Makes Sense As A Target, But Amgen Doesn't As A Buyer

Ref: Investor's Business Daily

Tags: NewsPoints Alexion Amgen Corporate Affairs Mergers & Acquisitions

Gilead and Galapagos Complete Closing of Their Transformative Research and Development Collaboration

Ref: GlobeNewswire

Tags: Press Release Galapagos Gilead Corporate Affairs Licensing

Kit de reconstitution et d'administration pour Nucala - Laboratoire GlaxoSmithKline - Rappel de lots

Ref: ANSM

Tags: Press Release GSK France ANSM Marketing & Sales Regulatory Affairs Nucala

Researchers advance organ-on-chip technology to advance drug development

Ref: Markets Insider

Tags: Press Release Arrhythmias Clinical Research (R&D) Medical Affairs

Researchers find a way to stop lung damage due to the body's immune response

Ref: ScienceDaily

Tags: NewsPoints Sepsis Clinical Research (R&D)

Aurobindo Pharma to launch 40 new products

Ref: Business Line

Tags: NewsPoints Aurobindo FDA Marketing & Sales Regulatory Affairs

Study suggests weight loss regardless of psychiatric medication use

Ref: ScienceDaily

Tags: NewsPoints Depression Obesity Clinical Research (R&D)

Progenics Investors Seek Changes at the Top as Activist Gains Traction

Ref: Bloomberg

Tags: NewsPoints Bausch Health Progenics Corporate Affairs Azedra Relistor